首页> 外国专利> Rh2 Rg3 Anticarcinogenic constituents of ginsenoside Rh2 and Rg3

Rh2 Rg3 Anticarcinogenic constituents of ginsenoside Rh2 and Rg3

机译:人参皂苷Rh2和Rg3的Rh2 Rg3抗癌成分

摘要

PURPOSE: Provided an anticancer composition of ginsenoside Rh2 and Rg3 which has improved anticancer effect without adverse side effect, thereby producing remedies or foods for the prevention and treatment of cancer using ginseng or red ginseng. CONSTITUTION: An anticancer composition of ginsenoside Rh2 and Rg3 is characterized by containing ginsenoside Rh2 and Rg3 in a ratio of 1:1 to 10:1. It further contains at least one or two pharmaceutically acceptable carriers selected from diluents, lubricants, disintegrant, binding agents, sweeteners, stabilizers and preservatives, or additives selected from flavorings, vitamin B group. The ginsenoside Rh2 and Rg3 are represented by the formula(1) and (2), respectively.
机译:目的:提供人参皂苷Rh2和Rg3的抗癌组合物,其具有改善的抗癌作用而没有不利的副作用,从而生产用于预防和治疗使用人参或红参的癌症的药物或食品。组成:人参皂甙Rh2和Rg3的抗癌组合物的特征在于其人参皂甙Rh2和Rg3的比例为1:1至10:1。它进一步包含至少一种或两种药学上可接受的载体,所述载体选自稀释剂,润滑剂,崩解剂,粘合剂,甜味剂,稳定剂和防腐剂,或选自调味剂,维生素B族的添加剂。人参皂苷Rh2和Rg3分别由式(1)和(2)表示。

著录项

  • 公开/公告号KR20040036092A

    专利类型

  • 公开/公告日2004-04-30

    原文格式PDF

  • 申请/专利权人 BIOSAPOGEN CO. LTD.;

    申请/专利号KR20020064895

  • 发明设计人 JUNG SANG SU;YOO YEONG HYO;

    申请日2002-10-23

  • 分类号A61K31/704;

  • 国家 KR

  • 入库时间 2022-08-21 22:49:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号